Skip to main content
Premium Trial:

Request an Annual Quote

Tom Schoenherr

Tom Schoenherr has been appointed as Ambry Genetics' chief commercial officer, following Ambry's acquisition by Konica Minolta in October. Previously, he led commercial strategy at Counsyl, and before that, he held similar roles at Quest, Siemens Healthcare, and Abbott Diagnostics.